Johnson & Johnson (JNJ) Net Margin (2009 - 2026)
Johnson & Johnson (JNJ) posted Net Margin of 21.86% for Q2 2026, little changed sequentially from 21.76% in Q1 2026, and down 146.0% YoY from 47.53% in Q2 2025.
Johnson & Johnson (JNJ) Net Margin (2009 - 2026) Analysis & Trends
Johnson & Johnson has reported Net Margin for 17 years, with the latest figure at 21.86% in Q2 2026.
- Quarterly Net Margin fell 146.0% year-over-year to 21.86% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 21.48% (up 324.0% YoY) and the FY2023 annual result came in at 25.63%, up 2367.0% from the prior year.
- Net Margin was little changed at 21.86% in Q2 2026 per JNJ's latest filing, from 21.76% in the prior quarter.
- Over five years, Net Margin peaked at 101.72% in Q4 2023 and troughed at 1.08% in Q3 2023.
- A 4-year average of 19.26% and a median of 11.87% in 2022 frame the typical range for Net Margin.
- The sharpest annual moves came in 2023 and 2026: Net Margin surged 10098 bps in 2023, then plunged 2848 bps in 2026.
- Over 4 years, Net Margin stood at 0.74% in 2022, then sank by 152 bps to 0.39% in 2023, then soared by 5469 bps to 20.83% in 2025, then advanced by 5 bps to 21.86% in 2026.
- According to Business Quant data, Net Margin over the past three periods registered 21.86%, 21.76%, and 20.83% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 21.28% |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | -8.05% |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 22.65% |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 16.30% |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | -1.58% |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | 5.17% |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn | 2.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 28, 2026 | 21.86% |
| Mar 29, 2026 | 21.76% |
| Dec 28, 2025 | 20.83% |
| Sep 28, 2025 | 21.47% |
| Jun 29, 2025 | 23.32% |
| Mar 30, 2025 | 50.24% |
| Dec 31, 2023 | -0.39% |
| Oct 1, 2023 | 101.72% |
| Jul 2, 2023 | -1.08% |
| Apr 2, 2023 | 2.02% |
| Jan 1, 2023 | 1.47% |
| Oct 2, 2022 | 0.74% |
| Jul 3, 2022 | 2.73% |
| Apr 3, 2022 | 2.91% |
| Oct 3, 2021 | 15.71% |
| Jul 4, 2021 | 26.93% |
| Apr 4, 2021 | 27.76% |
| Jan 3, 2021 | 7.73% |
| Sep 27, 2020 | 16.86% |
| Jun 28, 2020 | 19.78% |